202 related articles for article (PubMed ID: 29329575)
21. Overexpression of STAT4 under hypoxia promotes EMT through miR-200a/STAT4 signal pathway.
Li Y; Wang J; Chen W; Chen X; Wang J
Life Sci; 2021 May; 273():119263. PubMed ID: 33636177
[TBL] [Abstract][Full Text] [Related]
22. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y
Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
[TBL] [Abstract][Full Text] [Related]
23. MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression.
Shi W; Wang X; Ruan L; Fu J; Liu F; Qu J
Pharmazie; 2017 Nov; 72(11):694-699. PubMed ID: 29442045
[TBL] [Abstract][Full Text] [Related]
24. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1.
Yi D; Xu L; Wang R; Lu X; Sang J
Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer.
Liang Z; Feng A; Shim H
Cancer Chemother Pharmacol; 2020 Feb; 85(2):413-423. PubMed ID: 31907648
[TBL] [Abstract][Full Text] [Related]
26. miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis.
Yang RM; Zhan M; Xu SW; Long MM; Yang LH; Chen W; Huang S; Liu Q; Zhou J; Zhu J; Wang J
Cell Death Dis; 2017 Oct; 8(10):e3129. PubMed ID: 29048402
[TBL] [Abstract][Full Text] [Related]
27. miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells.
Xu X; Chen X; Xu M; Liu X; Pan B; Qin J; Xu T; Zeng K; Pan Y; He B; Sun H; Sun L; Wang S
Aging (Albany NY); 2019 Sep; 11(18):7357-7385. PubMed ID: 31543507
[TBL] [Abstract][Full Text] [Related]
28. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
29. miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer.
Liu F; Liu B; Qian J; Wu G; Li J; Ma Z
Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):520-529. PubMed ID: 28459992
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L
Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066
[TBL] [Abstract][Full Text] [Related]
31. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.
Roy SS; Gonugunta VK; Bandyopadhyay A; Rao MK; Goodall GJ; Sun LZ; Tekmal RR; Vadlamudi RK
Oncogene; 2014 Jul; 33(28):3707-16. PubMed ID: 23975430
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-1285 inhibits malignant biological behaviors of human pancreatic cancer cells by negative regulation of YAP1.
Huang H; Xiong G; Shen P; Cao Z; Zheng L; Zhang T; Zhao Y
Neoplasma; 2017; 64(3):358-366. PubMed ID: 28253715
[TBL] [Abstract][Full Text] [Related]
33. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836
[TBL] [Abstract][Full Text] [Related]
34. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
35. microRNA-200a inhibits cell proliferation by targeting mitochondrial transcription factor A in breast cancer.
Yao J; Zhou E; Wang Y; Xu F; Zhang D; Zhong D
DNA Cell Biol; 2014 May; 33(5):291-300. PubMed ID: 24684598
[TBL] [Abstract][Full Text] [Related]
36. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
37. microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1.
Wang H; Tan Z; Hu H; Liu H; Wu T; Zheng C; Wang X; Luo Z; Wang J; Liu S; Lu Z; Tu J
BMC Cancer; 2019 Jul; 19(1):738. PubMed ID: 31351450
[TBL] [Abstract][Full Text] [Related]
38. TNF-α/miR-155 axis induces the transformation of osteosarcoma cancer stem cells independent of TP53INP1.
Yao J; Lin J; He L; Huang J; Liu Q
Gene; 2020 Feb; 726():144224. PubMed ID: 31669646
[TBL] [Abstract][Full Text] [Related]
39. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.
Yao J; Xu F; Zhang D; Yi W; Chen X; Chen G; Zhou E
J Cell Biochem; 2018 Jan; 119(1):680-690. PubMed ID: 28639399
[TBL] [Abstract][Full Text] [Related]
40. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition.
Chen WY; Xu YY; Zhang XY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
